tirzepatide news september 27 2025 Eli Lilly temporarily halts UK shipments of weight-loss drug Mounjaro Tirzepatide vs Semaglutide: 2025 NEJM
Description
This content is for informational purposes only and is not medical advice
Semaglutide GLP-1 is a prescription medication used to treat obesity, a chronic metabolic condition
Developed by Novo Nordisk, Ozempic is a once-weekly injectable medication that mimics the effects of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1)
Your provider will review your health history to construct a sensible, individualized management plan
